Chargement en cours...
Warfarin Dosing in Patients With Impaired Kidney Function
BACKGROUND: Warfarin, a drug primarily metabolized by the cytochrome P450 system, is initiated at similar doses and managed similarly in patients with kidney impairment as in the general medical population. Unfortunately, few data exist to guide dose adjustment in patients with reduced kidney functi...
Enregistré dans:
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2010
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2963672/ https://ncbi.nlm.nih.gov/pubmed/20709439 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.ajkd.2010.05.023 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|